Interaction Guide · Research summary

Can I take Potassium Citrate with Lithium Citrate?

Review Potassium Citrate with Lithium Citrate: absorption and effectiveness and timing and monitoring, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Potassium citrate may lower lithium levels when used in amounts that act as an alkalinizing treatment. The concern is increased urinary lithium removal, and its size has not been measured for every product.

What this answer covers

Oral potassium citrate; label formulation is tripotassium citrate monohydrate extended-release, not every supplement dose.

Supplement or preparation
Potassium citrate
Medication ingredient
lithium citrate

A kidney-clearance concern

Potassium citrate can provide an alkaline load. The lithium solution label warns that alkalinizing agents can increase urinary lithium excretion and lower lithium concentrations. This supports a conditional concern about blood levels rather than a demonstrated reduction in gut absorption.

How directly this has been studied

The supporting potassium citrate label explains the product’s alkalinizing action, but does not report a lithium citrate coadministration experiment. The amount, formulation, kidney function and reason for treatment matter. A warning about medicinal alkali use cannot quantify every supplement or incidental food exposure.

Spacing does not resolve the mechanism

No reviewed source establishes that taking these products a few hours apart prevents the renal interaction. Nor does the lithium label require that every necessary alkalinizing treatment be abandoned. A clinician can assess whether a level check or treatment adjustment is appropriate.

Plan changes with the prescriber

Give the treating team the exact product and daily amount before starting, stopping or substantially changing it. If it is prescribed for a kidney or acid-base condition, coordinate changes with that clinician. Do not adjust lithium yourself to compensate for a possible interaction.

Evidence and practical considerations

Absorption & effectiveness

Narrow to possible lower lithium concentrations via renal excretion at meaningful alkalinizing exposure; no demonstrated impairment of absorption.

Exact scope
Oral potassium citrate; label formulation is tripotassium citrate monohydrate extended-release, not every supplement dose. with Lithium citrate oral solution, exact RxCUI 52105; current NLM IN. Carbonate evidence is indirect through lithium ion where stated.
Medication form and route
oral lithium citrate; oral supplement

What remains uncertain

  • Source-specific identity, preparation and endpoint limitations apply; no unstudied dose conversion.

Factors that may matter: Exact preparation; Amount and changes in use; Kidney function; Other medicines.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed lithium oral solution.

Lithium is eliminated mainly in urine. Sodium depletion can reduce clearance and raise levels; xanthines and alkalinizing agents can increase urinary excretion and lower levels. Serotonergic agents, explicitly including St John’s wort, increase serotonin-syndrome risk.

How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.

Lithium active-moiety bridge supports renal pharmacology across salts but not identical formulation kinetics, dose equivalence for self-use or quantified effects of every herb.

Source 2: product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Users of the specified oral preparation.

Oral potassium citrate metabolism produces an alkaline load, increasing urinary pH and citrate.

How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.

Establishes alkali class membership, not a direct lithium citrate interaction study or equivalence of all salt forms and supplement doses.

Research assessment: · Open full citations ↗

Timing & monitoring

No universal avoidance or effective spacing rule; clinician-managed co-use may require lithium monitoring.

Exact scope
Oral potassium citrate; label formulation is tripotassium citrate monohydrate extended-release, not every supplement dose. with Lithium citrate oral solution, exact RxCUI 52105; current NLM IN. Carbonate evidence is indirect through lithium ion where stated.
Medication form and route
oral lithium citrate; oral supplement

What remains uncertain

  • Source-specific identity, preparation and endpoint limitations apply; no unstudied dose conversion.

Factors that may matter: Exact preparation; Amount and changes in use; Kidney function; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed lithium oral solution.

Lithium is eliminated mainly in urine. Sodium depletion can reduce clearance and raise levels; xanthines and alkalinizing agents can increase urinary excretion and lower levels. Serotonergic agents, explicitly including St John’s wort, increase serotonin-syndrome risk.

How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.

Lithium active-moiety bridge supports renal pharmacology across salts but not identical formulation kinetics, dose equivalence for self-use or quantified effects of every herb.

Source 2: product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Users of the specified oral preparation.

Oral potassium citrate metabolism produces an alkaline load, increasing urinary pH and citrate.

How this applies: Only the stated identity, preparation, route and endpoints; limitations also govern extrapolation to the exact pair.

Establishes alkali class membership, not a direct lithium citrate interaction study or equivalence of all salt forms and supplement doses.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Prepared exact-pair article preserving salt, botanical and evidence limitations.
Research summary published

Article revision: 19c01a0864b2a048

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.